retatrutide fda approval status HAS NOT BEEN APPROVED YET & CURRENTLY IN PHASE III CLINICAL TRIALS⛔️ Retatrutide is not currently FDA-approved, as it is in Phase III clinical trials with anticipated completion in 2025–2026 and Some Providers Prescribe Unapproved Retatrutide

Your care team can offer guidance and help ensure your first week of treatment is as comfortable as possible

Without the medication's appetite-suppressing effects, portion sizes naturally increase, and cravings for calorie-dense foods often return

During the discovery phase, both parties are able to gather and exchange information about the case, including evidence and potential witnesses that may be used at trial

The risk of the drugs effects stacking on top of the diseases effects is simply too high for many clinicians to recommend

Lyophilized GLP-RT is typically stored at approximately 4 F (20 C), protected from light and moisture